Gary Hennerberg
Direktor/Vorstandsmitglied bei BIOREGENX, INC.
Vermögen: 525 955 $ am 31.05.2024
Aktive Positionen von Gary Hennerberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOREGENX, INC. | Direktor/Vorstandsmitglied | 08.03.2024 | - |
| Unternehmenssekretär | 08.03.2024 | - |
Karriereverlauf von Gary Hennerberg
Ehemalige bekannte Positionen von Gary Hennerberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Direktor/Vorstandsmitglied | 01.05.2016 | - |
| Vertrieb & Marketing | 01.05.2016 | - |
Ausbildung von Gary Hennerberg
| Fort Hays State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| 2 |
Operativ
| Director/Board Member | 2 |
| Sales & Marketing | 1 |
| Corporate Secretary | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
| Findit, Inc. |
- Börse
- Insiders
- Gary Hennerberg
- Erfahrung